Barclays’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-6,285
| Closed | -$325K | – | 4952 |
|
|
2020
Q3 | $325K | Hold |
6,285
| – | – | ﹤0.01% | 3526 |
|
|
2020
Q2 | $310K | Sell |
6,285
-16,970
| -73% | -$916K | ﹤0.01% | 3724 |
|
|
2020
Q1 | $1.19M | Buy |
23,255
+10,811
| +87% | +$623K | ﹤0.01% | 2780 |
|
|
2019
Q4 | $686K | Buy |
12,444
+9,679
| +350% | +$525K | ﹤0.01% | 4017 |
|
|
2019
Q3 | $139K | Sell |
2,765
-1,006
| -27% | -$50.5K | ﹤0.01% | 5218 |
|
|
2019
Q2 | $190K | Buy |
3,771
+2,514
| +200% | +$122K | ﹤0.01% | 5162 |
|
|
2019
Q1 | $58K | Buy |
1,257
+1,006
| +401% | +$51K | ﹤0.01% | 5752 |
|
|
2018
Q4 | $12K | Sell |
251
-3,646
| -94% | -$207K | ﹤0.01% | 6099 |
|
|
2018
Q3 | $242K | Buy |
+3,897
| New | +$237K | ﹤0.01% | 4854 |
|
|
2018
Q2 | – | Sell |
-126
| Closed | -$6K | – | 7033 |
|
|
2018
Q1 | $6K | Sell |
126
-5,153
| -98% | -$221K | ﹤0.01% | 6751 |
|
|
2017
Q4 | $208K | Buy |
5,279
+251
| +5% | +$9.55K | ﹤0.01% | 4659 |
|
|
2017
Q3 | $185K | Buy |
5,028
+2,514
| +100% | +$89.6K | ﹤0.01% | 4492 |
|
|
2017
Q2 | $97K | Buy |
2,514
+2,137
| +567% | +$78.3K | ﹤0.01% | 4934 |
|
|
2017
Q1 | $13K | Buy |
+377
| New | +$12.4K | ﹤0.01% | 5975 |
|
|
2016
Q4 | – | Sell |
-9,176
| Closed | -$296K | – | 6658 |
|
|
2016
Q3 | $296K | Buy |
9,176
+1,257
| +16% | +$40.7K | ﹤0.01% | 3639 |
|
|
2016
Q2 | $245K | Buy |
7,919
+7,416
| +1,474% | +$232K | ﹤0.01% | 3771 |
|
|
2016
Q1 | $15K | Sell |
503
-2,011
| -80% | -$55.5K | ﹤0.01% | 5328 |
|
|
2015
Q4 | $68K | Sell |
2,514
-12,947
| -84% | -$368K | ﹤0.01% | 4627 |
|
|
2015
Q3 | $467K | Buy |
15,461
+4,274
| +38% | +$149K | ﹤0.01% | 3398 |
|
|
2015
Q2 | $409K | Buy |
11,187
+9,301
| +493% | +$332K | ﹤0.01% | 3635 |
|
|
2015
Q1 | $66K | Buy |
1,886
+1,132
| +150% | +$38.7K | ﹤0.01% | 5116 |
|
|
2014
Q4 | $23K | Sell |
754
-7,039
| -90% | -$219K | ﹤0.01% | 6248 |
|
|
2014
Q3 | $223K | Buy |
7,793
+1,005
| +15% | +$30.6K | ﹤0.01% | 4652 |
|
|
2014
Q2 | $189K | Buy |
+6,788
| New | +$189K | ﹤0.01% | 4872 |
|
|
2014
Q1 | – | Sell |
-2,514
| Closed | -$66K | – | 7588 |
|
|
2013
Q4 | $66K | Sell |
2,514
-377
| -13% | -$10.5K | ﹤0.01% | 5984 |
|
|
2013
Q3 | $78K | Sell |
2,891
-5,782
| -67% | -$148K | ﹤0.01% | 5809 |
|
|
2013
Q2 | $199K | Buy |
+8,673
| New | +$196K | ﹤0.01% | 5179 |
|
Other funds holding EHC
VPM
VCM
Barclays's EHC Position: Q1 2026 in Review
Barclays increased its Encompass Health (EHC) stake by 32% in Q1 2026, buying an estimated $8.17M and bringing the position to 328,547 shares worth $31.8M. The position accounts for 0.01% of the portfolio, ranked #909.
Barclays first reported a position in EHC in Q2 2013 and has held it in 52 quarters since. 578 funds tracked by Wall St. Rank hold EHC as of Q1 2026.
- Barclays held 328,547 shares of Encompass Health worth $31.8M as of Q1 2026.
- Barclays bought 79,662 Encompass Health shares in Q1 2026, an estimated $8.17M.
- Encompass Health made up 0.01% of Barclays's portfolio in Q1 2026, its #909 holding.
- Barclays first reported a position in Encompass Health in Q2 2013 and has held it in 52 quarters since.
- 578 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.